Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15752234 | 1.00 | POLB (0.46) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL9828728 | 0.78 | ALDH1A1 (0.48) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL9828729 | 0.78 | ALDH1A1 (0.48) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL13416406 | 0.76 | ALOX15 (0.56) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL28646933 | 0.73 | ALOX15 (0.58) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL10504078 | 0.73 | POLB (0.58) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL27742265 | 0.73 | POLB (0.49) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL9491963 | 0.72 | HDAC3 (0.52) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL29050657 | 0.72 | POLB (0.61) | POLBHDAC3CA12CA1IDO1 | |
| SCHEMBL9987055 | 0.71 | POLB (0.50) | POLBHDAC3CA12CA1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2044436-B1 | METHODS AND COMPOSITIONS FOR DETECTION OF MICROORGANISMS AND CELLS AND TREATMENT OF DISEASES AND DISORDERS | GENELUX CORP (US) | 2014-06-04 | — | — | EP | disclosed |
| US-20120021450-A1 | METHODS FOR MAGNETIC RESONANCE IMAGING | CARNEGIE MELLON UNIVERSITY (US) | 2012-01-26 | — | — | US | disclosed |
| US-8084017-B2 | In situ genetic engineering; generating image | CARNEGIE MELLON UNIVERSITY (US) | 2011-12-27 | — | — | US | disclosed |
| US-7998704-B2 | Methods for magnetic resonance imaging | CARNEGIE MELLON UNIVERSITY (US) | 2011-08-16 | — | — | US | disclosed |
| US-7820184-B2 | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders | GENELUX CORPORATION (US) | 2010-10-26 | — | — | US | disclosed |
| US-7763420-B2 | administering an Escherichia bacterium strain and detecting the bacterium to indicate the site of proliferation or proliferative conditions selected from tumors, injuries and inflammation | GENELUX CORPORATION (US) | 2010-07-27 | — | — | US | disclosed |
| US-20090180987-A1 | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders | GENELUX CORPORATION | 2009-07-16 | — | — | US | disclosed |
| US-20080193373-A1 | administering an Escherichia bacterium strain and detecting the bacterium to indicate the site of proliferation or proliferative conditions selected from tumors, injuries and inflammation | GENELUX CORPORATION | 2008-08-14 | — | — | US | disclosed |
| EP-1874335-A2 | METHODS FOR MAGNETIC RESONANCE IMAGING | CARNEGIE-MELLON UNIVERSITY (US) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006099516-A2 | METHODS FOR MAGNETIC RESONANCE IMAGING | CARNEGIE MELLON UNIVERSITY (US) | 2006-09-21 | — | — | WO | disclosed |
| US-20060024662-A1 | Methods for magnetic resonance imaging | CARNEGIE MELLON UNIVERSITY (US) | 2006-02-02 | — | — | US | disclosed |
| US-20030232040-A1 | Biocidal methods and compositions | SURECIDE TECHNOLOGIES, LLC | 2003-12-18 | — | — | US | disclosed |
| US-20030219385-A1 | Contrast agents for magnetic resonance imaging and methods related thereto | CARNEGIE MELLON UNIVERSITY | 2003-11-27 | — | — | US | disclosed |
| EP-1265490-A1 | BIOCIDAL METHODS AND COMPOSITIONS | Surecide Technologies, LLC (US) | 2002-12-18 | — | — | EP | disclosed |
| US-20020015697-A1 | Biocidal methods and compositions | SURECIDE, LLC | 2002-02-07 | — | — | US | disclosed |
| WO-2001067878-A1 | BIOCIDAL METHODS AND COMPOSITIONS | SURECIDE TECHNOLOGIES, LLC (US) | 2001-09-20 | — | — | WO | disclosed |
| US-6030653-A | Inactivation of iron dependent bacterium using visible and near infrared light | ROSENTHAL RICHARD A (US) | 2000-02-29 | — | — | US | disclosed |